Abstract Form

Title: Surgical Management of Glaucoma in Fuchs Uveitis Syndrome: Trabeculectomy versus Ahmed Glaucoma Valve
Author(s): Naveed Nilforushan MD, Maryam Yadgari MD, Sayyed Amirpooya Alemzadeh MD , Kia Vosoughi MD
Presentation Type: Oral
Subject: Glaucoma
Others:
Presenting Author:
Name: Naveed Nilforushan
Affiliation :(optional) Eye research center, Rassoul Akram Hospital,Iran University of Medical Sciences, Tehran, Iran
E mail: naveednil@yahoo.com
Phone: 88032410
Mobile: 09123576823
Abstract (Max 200 words)
Purpose: To compare the outcome of trabeculectomy versus Ahmed glaucoma valve (AGV) surgery in patients with Fuchs Uveitis Syndrome.
Methods: Twenty eight eyes of 28 patients (13 male and 15 female) with medically uncontrolled glaucoma associated with Fuchs Uveitis Syndrome that underwent glaucoma surgery (16 eyes with trabeculectomy and 12 eyes with AGV surgery) were enrolled in this study. The primary outcome measure was surgical success defined in terms of intraocular pressure (IOP) control using two criteria. Success was defined as IOP ≤ 21 mmHg (criterion A) and IOP ≤ 16 mmHg (criterion B), with at least 20% reduction in IOP, either with no medication (complete success) or with no more than pre operative medications (qualified success). The sum of complete and qualified success was defined as cumulative success.
Results: Mean age of patients in trabeculectomy group and AGV group was 44.92 ± 9.02 and 45.76 ± 7.10, respectively (P= 0.79). Mean duration of follow up was 23.06 ± 12.03 months (range 6-36 months) in trabeculectomy group and 22.83 ± 13.63 months (range 6-36 months) in AGV group (P= 0.083).Cumulative Success rate in trabeculectomy group is higher than that of AGV group based on criteria A and B. Finally Kaplan-Meier survival analysis revealed significant association between surgical method and cumulative success rate over 36 months (based on criteria A: p=0.02, and based on criteria B: p=0.007).
Conclusion: Trabeculectomy had higher success rate than AGV in management of glaucoma in patients with FUS.
Attachment: